International Journal of Cancer Management

Published by: Kowsar

Cancer Incidence Rate in the Elderly Inhabitants of Tehran: Is there Really any Cluster?

Marzieh Rohani-Rasaf 1 , Mohammad Reza Rohani-Rasaf 2 , Seyed Saeed Hashemi Nazari 3 , Abdollah Mohammadian-Hafshejani 4 and Mohsen Asadi-Lari 5 , *
Authors Information
1 Student Research Committee, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Geography and Urban Planning Department, Shahid Chamran University of Ahvaz, Ahvaz, IR Iran
3 Safety Promotion and Injury Prevention Research Center AND Department of Epidemiology, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Department of Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
5 Associate Professor of Epidemiology, Oncopathology Research Centre, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: July 2017, 10 (7); e5753
  • Published Online: July 31, 2017
  • Article Type: Research Article
  • Received: February 21, 2016
  • Revised: October 10, 2016
  • Accepted: July 8, 2017
  • DOI: 10.5812/ijcm.5753

To Cite: Rohani-Rasaf M, Rohani-Rasaf M R, Hashemi Nazari S S, Mohammadian-Hafshejani A, Asadi-Lari M. Cancer Incidence Rate in the Elderly Inhabitants of Tehran: Is there Really any Cluster?, Int J Cancer Manag. 2017 ; 10(7):e5753. doi: 10.5812/ijcm.5753.

Abstract
Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Global Health and Aging: National Institute on Aging, October 2011 Contract No. 2011;
  • 2. Health. 2012;
  • 3. Ukraintseva S, Yashin AI. Individual Aging and Cancer Risk: How are They Related? Demograph Res. 2003; 9: 163-96[DOI]
  • 4. Baranovsky A, Myers MH. Cancer incidence and survival in patients 65 years of age and older. CA Cancer J Clin. 1986; 36(1): 26-41[PubMed]
  • 5. Berger NA, Savvides P, Koroukian SM, Kahana EF, Deimling GT, Rose JH, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc. 2006; 117: 147-55[PubMed]
  • 6. Dix D, Cohen P. On the role of aging in carcinogenesis. Anticancer Res. 1999; 19(1B): 723-6[PubMed]
  • 7. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001; 37 Suppl 8-66[PubMed]
  • 8. Dix D. The role of aging in cancer incidence: an epidemiological study. J Gerontol. 1989; 44(6): 10-8[PubMed]
  • 9. Pearce J, Boyle P. Examining the relationship between lung cancer and radon in small areas across Scotland. Health Place. 2005; 11(3): 275-82[DOI][PubMed]
  • 10. Morra P, Bagli S, Spadoni G. The analysis of human health risk with a detailed procedure operating in a GIS environment. Environ Int. 2006; 32(4): 444-54[DOI][PubMed]
  • 11. Elliott P, Wakefield J, Best N, Briggs D. Spatial Epidemiology: Methods and Applications. 2001;
  • 12. Flinton DM, Walters NJ. Occupational activity and risk of prostate cancer in Ireland. J Radiother Pract. 2005; 4(2-3): 102-6[DOI]
  • 13. Roche LM, Skinner R, Weinstein RB. Use of a geographic information system to identify and characterize areas with high proportions of distant stage breast cancer. J Public Health Manag Pract. 2002; 8(2): 26-32[PubMed]
  • 14. Pickle LW, Waller LA, Lawson AB. Current practices in cancer spatial data analysis: a call for guidance. Int J Health Geogr. 2005; 4(1): 3[DOI][PubMed]
  • 15. Basanez MG. Pfeiffer DU, Robinson TP, Stevenson M, Stevens KB, Rogers DJ, Clements ACA: Spatial Analysis in Epidemiology. 2009;
  • 16. Walter SD. The analysis of regional patterns in health data. I. Distributional considerations. Am J Epidemiol. 1992; 136(6): 730-41[PubMed]
  • 17. Walter SD. The analysis of regional patterns in health data. II. The power to detect environmental effects. Am J Epidemiol. 1992; 136(6): 742-59[PubMed]
  • 18. Ahmad O, Boschi-Pinto C, Lopez A, Murray C, Lozano R, Inoue M. Age standardization of rates:A new WHO standard. GPE Discussion Paper Series:No.31.Geneva EIP/GPE/EBD. 2009;
  • 19. Lalor GC, Zhang C. Multivariate outlier detection and remediation in geochemical databases. Sci Total Environ. 2001; 281(1-3): 99-109[PubMed]
  • 20. Anselin L. Local indicators of spatial association—LISA. Geograph Analysis. 1995; 27(2): 93-115
  • 21. Anisimov VN. Carcinogenesis and aging. Adv Cancer Res. 1983; 40: 365-424[PubMed]
  • 22. Anisimov VN, Petrov NN. Carcinogenesis and aging. 1987;
  • 23. Balducci L, Ershler WB, Lyman GH, Extermann M. Comprehensive geriatric oncology. 2004;
  • 24. Hansen J. Common cancers in the elderly. Drugs Aging. 1998; 13(6): 467-78[PubMed]
  • 25. Scosyrev E, Messing EM, Mohile S, Golijanin D, Wu G. Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. Cancer. 2012; 118(12): 3062-70[DOI][PubMed]
  • 26. Cancer Incidence and Mortality Worldwide in 2008. 2010;
  • 27. Gregorio DI, Samociuk H. Prostate cancer incidence in light of the spatial distribution of another screening-detectable cancer. Spat Spatiotemporal Epidemiol. 2013; 6: 1-6[DOI][PubMed]
  • 28. Gregorio DI, Kulldorff M, Sheehan TJ, Samociuk H. Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998. Urology. 2004; 63(1): 78-82[PubMed]
  • 29. Aarts MJ, Koldewijn EL, Poortmans PM, Coebergh JW, Louwman M. The impact of socioeconomic status on prostate cancer treatment and survival in the southern Netherlands. Urology. 2013; 81(3): 593-9[DOI][PubMed]
  • 30. Mokete M, Shackley DC, Betts CD, O'Flynn KJ, Clarke NW. The increased rate of prostate specific antigen testing has not affected prostate cancer presentation in an inner city population in the UK. BJU Int. 2006; 97(2): 266-9[DOI][PubMed]
  • 31. Baade PD, Yu XQ, Smith DP, Dunn J, Chambers SK. Geographic disparities in prostate cancer outcomes--review of international patterns. Asian Pac J Cancer Prev. 2015; 16(3): 1259-75[PubMed]
  • 32. Altekruse SF, Huang L, Cucinelli JE, McNeel TS, Wells KM, Oliver MN. Spatial patterns of localized-stage prostate cancer incidence among white and black men in the southeastern United States, 1999-2001. Cancer Epidemiol Biomarkers Prev. 2010; 19(6): 1460-7[DOI][PubMed]
  • 33. Oliver MN, Smith E, Siadaty M, Hauck FR, Pickle LW. Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999. Am J Prev Med. 2006; 30(2 Suppl)-76[DOI][PubMed]
  • 34. Major JM, Norman Oliver M, Doubeni CA, Hollenbeck AR, Graubard BI, Sinha R. Socioeconomic status, healthcare density, and risk of prostate cancer among African American and Caucasian men in a large prospective study. Cancer Causes Control. 2012; 23(7): 1185-91[DOI][PubMed]
  • 35. Shafique K, Oliphant R, Morrison DS. The impact of socio-economic circumstances on overall and grade-specific prostate cancer incidence: a population-based study. Br J Cancer. 2012; 107(3): 575-82[DOI][PubMed]
  • 36. Cheng I, Witte JS, McClure LA, Shema SJ, Cockburn MG, John EM, et al. Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California. Cancer Causes Control. 2009; 20(8): 1431-40[DOI][PubMed]
  • 37. Torres-Cintron M, Ortiz AP, Ortiz-Ortiz KJ, Figueroa-Valles NR, Perez-Irizarry J, Diaz-Medina G, et al. Using a socioeconomic position index to assess disparities in cancer incidence and mortality, Puerto Rico, 1995-2004. Prev Chronic Dis. 2012; 9[PubMed]
  • 38. Nielsen NR, Kristensen TS, Zhang ZF, Strandberg-Larsen K, Schnohr P, Gronbaek M. Sociodemographic status, stress, and risk of prostate cancer. A prospective cohort study. Ann Epidemiol. 2007; 17(7): 498-502[DOI][PubMed]
  • 39. Rohani-Rasaf M, Moradi-Lakeh M, Ramezani R, Asadi-Lari M. Measuring socioeconomic disparities in cancer incidence in Tehran, 2008. Asian Pac J Cancer Prev. 2012; 13(6): 2955-60[PubMed]
  • 40. Iran Cancer Registration Report, 2006. 2010;
  • 41. Gallagher LG, Webster TF, Aschengrau A, Vieira VM. Using residential history and groundwater modeling to examine drinking water exposure and breast cancer. Environ Health Perspect. 2010; 118(6): 749-55[DOI][PubMed]
  • 42. Dai D, Oyana TJ. Spatial variations in the incidence of breast cancer and potential risks associated with soil dioxin contamination in Midland, Saginaw, and Bay Counties, Michigan, USA. Environ Health. 2008; 7: 49[DOI][PubMed]
  • 43. Montazeri A, Sadighi J, Farzadi F, Maftoon F, Vahdaninia M, Ansari M, et al. Weight, height, body mass index and risk of breast cancer in postmenopausal women: a case-control study. BMC Cancer. 2008; 8: 278[DOI][PubMed]
  • 44. Beiki O, Hall P, Ekbom A, Moradi T. Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study. Breast Cancer Res. 2012; 14(1)[DOI][PubMed]
  • 45. Larsen SB, Olsen A, Lynch J, Christensen J, Overvad K, Tjonneland A. Socioeconomic position and lifestyle in relation to breast cancer incidence among postmenopausal women: a prospective cohort study, Denmark, 1993-2006. Cancer Epidemiol. 2011; 35(5): 438-41
  • 46. Palmer JR, Boggs DA, Wise LA, Adams-Campbell LL, Rosenberg L. Individual and neighborhood socioeconomic status in relation to breast cancer incidence in African-American women. Am J Epidemiol. 2012; 176(12): 1141-6[DOI][PubMed]
  • 47. Glaser SL. Spatial clustering of Hodgkin's disease in the San Francisco Bay area. Am J Epidemiol. 1990; 132(1 Suppl)-77[PubMed]
  • 48. Waltz P, Chodick G. Assessment of ecological regression in the study of colon, breast, ovary, non-Hodgkin's lymphoma, or prostate cancer and residential UV. Eur J Cancer Prev. 2008; 17(3): 279-86[DOI][PubMed]
  • 49. Diaz Mdel P, Osella AR, Aballay LR, Munoz SE, Lantieri MJ, Butinof M, et al. Cancer incidence pattern in Cordoba, Argentina. Eur J Cancer Prev. 2009; 18(4): 259-66[DOI][PubMed]
  • 50. Vieira V, Webster T, Weinberg J, Aschengrau A. Spatial analysis of bladder, kidney, and pancreatic cancer on upper Cape Cod: an application of generalized additive models to case-control data. Environ Health. 2009; 8: 3[DOI][PubMed]
  • 51. Boeglin ML, Wessels D, Henshel D. An investigation of the relationship between air emissions of volatile organic compounds and the incidence of cancer in Indiana counties. Environ Res. 2006; 100(2): 242-54[DOI][PubMed]
  • 52. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, Nicolli H, et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology. 1996; 7(2): 117-24[PubMed]
  • 53. Soderlund S, Granath F, Brostrom O, Karlen P, Lofberg R, Ekbom A, et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology. 2010; 138(5): 1697-703[DOI][PubMed]
  • 54. Mohebbi M, Mahmoodi M, Wolfe R, Nourijelyani K, Mohammad K, Zeraati H, et al. Geographical spread of gastrointestinal tract cancer incidence in the Caspian Sea region of Iran: spatial analysis of cancer registry data. BMC Cancer. 2008; 8: 137[DOI][PubMed]
  • 55. Rohani-Rasaf M, Abdollahi M, Jazayeri S, Kalantari N, Asadi-Lari M. Correlation of cancer incidence with diet, smoking and socio- economic position across 22 districts of Tehran in 2008. Asian Pac J Cancer Prev. 2013; 14(3): 1669-76[PubMed]
  • 56. Shah SA, Neoh HM, Rahim SS, Azhar ZI, Hassan MR, Safian N, et al. Spatial analysis of colorectal cancer cases in Kuala Lumpur. Asian Pac J Cancer Prev. 2014; 15(3): 1149-54[PubMed]
  • 57. DeChello LM, Sheehan TJ. Spatial analysis of colorectal cancer incidence and proportion of late-stage in Massachusetts residents: 1995-1998. Int J Health Geogr. 2007; 6: 20[DOI][PubMed]
  • 58. Takahashi T, Schoemaker MJ, Trott KR, Simon SL, Fujimori K, Nakashima N, et al. The relationship of thyroid cancer with radiation exposure from nuclear weapon testing in the Marshall Islands. J Epidemiol. 2003; 13(2): 99-107[PubMed]
  • 59. Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, Khrouch V, et al. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst. 2005; 97(10): 724-32[DOI][PubMed]
  • 60. Acharya S, Sarafoglou K, LaQuaglia M, Lindsley S, Gerald W, Wollner N, et al. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence. Cancer. 2003; 97(10): 2397-403[DOI][PubMed]
  • 61. Schonfeld SJ, Lee C, Berrington de Gonzalez A. Medical exposure to radiation and thyroid cancer. Clin Oncol (R Coll Radiol). 2011; 23(4): 244-50[DOI][PubMed]
  • 62. Shibata Y, Yamashita S, Masyakin VB, Panasyuk GD, Nagataki S. 15 years after Chernobyl: new evidence of thyroid cancer. Lancet. 2001; 358(9297): 1965-6[DOI][PubMed]
  • 63. Veiga LH, Bhatti P, Ronckers CM, Sigurdson AJ, Stovall M, Smith SA, et al. Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev. 2012; 21(1): 92-101[DOI][PubMed]
  • 64. Leux C, Guenel P. Risk factors of thyroid tumors: role of environmental and occupational exposures to chemical pollutants. Rev Epidemiol Sante Publique. 2010; 58(5): 359-67[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments